Skip to main content
PLOS One logoLink to PLOS One
. 2024 Jun 11;19(6):e0305128. doi: 10.1371/journal.pone.0305128

Trends in degenerative lumbar spinal surgery during the early COVID-19 pandemic in Republic of Korea: A national study utilizing the national health insurance database

Woon Tak Yuh 1,2,#, Jinhee Kim 3,#, Mi-Sook Kim 3,4,, Jun-Hoe Kim 5, Young Rak Kim 5, Sum Kim 5, Chun Kee Chung 5,6,7, Chang-Hyun Lee 5,6, Sung Bae Park 5,6,8, Kyoung-Tae Kim 9,10, John M Rhee 11, Young San Ko 9, Chi Heon Kim 5,6,12,‡,*
Editor: Kentaro Yamada13
PMCID: PMC11166321  PMID: 38861502

Abstract

During the first year of the COVID-19 pandemic, the Republic of Korea (ROK) experienced three epidemic waves in February, August, and November 2020. These waves, combined with the overarching pandemic, significantly influenced trends in spinal surgery. This study aimed to investigate the trends in degenerative lumbar spinal surgery in ROK during the early COVID-19 pandemic, especially in relation to specific epidemic waves. Using the National Health Information Database in ROK, we identified all patients who underwent surgery for degenerative lumbar spinal diseases between January 1, 2019 and December 31, 2020. A joinpoint regression was used to assess temporal trends in spinal surgeries over the first year of the COVID-19 pandemic. The number of surgeries decreased following the first and second epidemic waves (p<0.01 and p = 0.34, respectively), but these were offset by compensatory increases later on (p<0.01 and p = 0.05, respectively). However, the third epidemic wave did not lead to a decrease in surgical volume, and the total number of surgeries remained comparable to the period before the pandemic. When compared to the pre-COVID-19 period, average LOH was reduced by 1 day during the COVID-19 period (p<0.01), while mean hospital costs increased significantly from 3,511 to 4,061 USD (p<0.01). Additionally, the transfer rate and the 30-day readmission rate significantly decreased (both p<0.01), while the reoperation rate remained stable (p = 0.36). Despite the impact of epidemic waves on monthly surgery numbers, a subsequent compensatory increase was observed, indicating that surgical care has adapted to the challenges of the pandemic. This adaptability, along with the stable total number of operations, highlights the potential for healthcare systems to continue elective spine surgery during public health crises with strategic resource allocation and patient triage. Policies should ensure that surgeries for degenerative spinal diseases, particularly those not requiring urgent care but crucial for patient quality of life, are not unnecessarily halted.

Introduction

The first COVID-19 patient was reported in November 2019 in China, and the World Health Organization officially declared COVID-19 to be a global pandemic on March 11, 2020. In the Republic of Korea (ROK), the first case of COVID-19 was confirmed on January 20, 2020, and the level of quarantine was raised to the highest level on February 23, 2020. The entire nation was locked down, and only essential activities were allowed [1].

The COVID-19 pandemic has presented unprecedented challenges for patients and the healthcare community as a whole [211]. Due to the increased number of infected individuals, sick patients, and social distancing, medical resources such as hospital beds and medical personnel have had to be practically re-distributed. While the main guidelines and strategies in every country were similar, the healthcare infrastructure and pandemic responses, including spinal surgery varied among countries [12,13]. For example, in ROK, all people are beneficiary of national health insurance or medical aid, and the access to any hospital is not limited to place. During the COVID-19 pandemic, the government of ROK did not restrict elective surgical procedures officially. On the other hand, in the USA, the COVID-19 pandemic led to a nationwide suspension of elective surgery, including spinal procedures, from March 2020 to May 2020 [14].

Although the government of ROK did not officially restrict elective spinal surgeries during the pandemic, the conditions for such surgeries changed significantly. First, the number of hospital beds available for elective surgery decreased. Although restrictions or delays of elective surgery were not recommended, public hospitals, university hospitals, and large private hospitals were required to secure hospital beds and intensive care unit space for COVID-19 patients to accommodate the increasing number of COVID-19 patients. Additionally, social distancing measures reduced the density of hospital beds in a single hospital room compared to the previous circumstances where there had been up to 6 beds in one room. Second, patients could only be admitted if they had a negative polymerase chain reaction (PCR) test and showed no symptoms of COVID-19. Third, patients were concerned about the possibility of nosocomial COVID-19 infections during their hospital stay [15]. Due to those and other unmentioned reasons, the patterns of medical services in spinal surgery may have been affected.

Surgical interventions for degenerative lumbar spinal disease are typically elective and focused on enhancing quality of life rather than addressing emergencies that threaten life immediately. As a result, these conditions are often assigned a lower priority compared to other spinal diseases such as cervical or thoracic lesions with neurological deficits or spinal traumas requiring urgent surgical interventions. In the initial stages of the COVID-19 pandemic, elective surgeries for degenerative lumbar diseases were frequently deferred or canceled as medical priorities shifted to pandemic management. This practice, although intended to conserve medical resources for acute pandemic care, was found to potentially worsen the long-term quality of life of these patients, increasing their vulnerability as the pandemic protracted [12,1419]. Based on this experience, this study was designed to observe the impact of the COVID-19 pandemic on surgeries for patients with degenerative lumbar spinal disease who are vulnerable during pandemics. The primary aim of this study was to examine trends in lumbar spinal surgery during the early COVID-19 pandemic in ROK, according to specific epidemic waves. The secondary aims included comparing detailed outcomes, including length of hospital stay (LOH), hospital costs, discharge disposition, the 30-day readmission rate, and the reoperation rate between before and during the COVID-19 pandemic.

Materials and methods

National health information database (NHID)

This study utilized the National Health Information Database (NHID) from the National Health Insurance Service (NHIS) of ROK. In ROK, nearly all residents are beneficiaries of the national health insurance system, and all nationwide inpatient and outpatient data regarding diseases and services (i.e., procedures and operations) are coded and registered in the NHID and the Health Insurance Review & Assessment Service (HIRA) database, thus enabling population-based studies to be conducted [2022]. The NHID contains demographic characteristics and insurance eligibility information, as well as data on almost all hospitalizations and outpatient medical services. This information encompasses diagnoses, which are based on International Classification of Diseases 10th Revision codes, procedures, prescriptions, examinations, and direct medical costs. Since medical service providers electronically submit claims data to the HIRA for reimbursement, and the HIRA reviews them to determine payment eligibility, the information on procedures and medical costs is highly accurate. Given that almost all hospitals in ROK adhere to the NHIS for reimbursement, healthcare utilization records of almost all patients who underwent lumbar spinal surgery could be extracted from the claims data through the NHID. The data are provided after pseudonymization and can only be accessed remotely in a strictly controlled analysis room. Therefore, the Institutional Review Board waived informed consent. The NHID was accessed from November 8, 2021, through August 11, 2023, for the purposes of this research. During and after data collection, the authors did not have access to information that could identify individual participants. All methods were performed in accordance with the relevant guidelines and regulation, and the Institutional Review Board of the Seoul National University Hospital approved the review and analysis of the data (2012-014-1177).

COVID-19 epidemic waves in ROK

While there is no universally accepted definition of an epidemic wave, Salyer et al. defined an epidemic wave or phase as a rising number of COVID-19 cases with a defined peak, followed by a decline in cases or trough period, in which transmission had decreased [23]. We retrieved the data for daily confirmed COVID-19 cases in 2020 from the Korea Disease Control and Prevention Agency (KDCA) website (https://ncov.kdca.go.kr/en/) with an aim to investigate patterns and determine if there was any epidemic wave. Using the definition provided by Salyer et al., we identified three distinct epidemic waves in ROK during the initial year of the COVID-19 pandemic. These occurred from February 18th to March 14th, August 13th to September 5th, and November 6th to December 31st, 2020. Each wave reached its peak on February 29th, August 27th, and December 25th, 2020, respectively (Fig 1A).

Fig 1. Analysis of surgical operations in relation to the epidemic waves in ROK.

Fig 1

(a) Weekly count of operations juxtaposed with daily cases of COVID-19. Decreases in weekly operations were observed following the first and second epidemic waves, with compensatory increases occurring in May and October. Notably, the third wave did not result in any discernible decrease or subsequent compensatory increase. (b) Joinpoint regression analysis: A significant decrease in the number of operations was observed during the first epidemic wave (p<0.01). The decline during the second epidemic wave did not achieve statistical significance (p = 0.34). Following both the first and second waves, compensatory increases in surgical operations were documented (both p≤0.05). Interestingly, neither a decrease nor a compensatory increase was evident during the third epidemic wave. WPC, weekly percentage change; AWPC, average weekly percentage change.

Patient inclusion

Patients who underwent lumbar spinal surgery with the diagnosis of herniated intervertebral disc disease (HIVD), lumbar spinal stenosis (LSS), spondylolisthesis, and spondylolysis from 2019 to 2020 were selected to investigate trends in spinal surgery using the number of surgical operations per week. These diagnoses were based on the International Classification of Diseases 10th Revision (ICD-10) codes: HIVD (M51.x), LSS (M48.05, M48.06, M48.07, M48.08), spondylolisthesis (M43.15, M43.16, M43.17, M43.18, M53.26), and spondylolysis (M43.06, M43.07, M43.08). When patients had multiple spinal diseases, the representative disease code followed the hierarchical coding algorithm proposed by Martin et al. [24]. For example, if patients were diagnosed with both spondylolisthesis and HIVD, they were categorized as having spondylolisthesis. Surgical methods were primarily divided into decompression only or fusion surgery. For patients with HIVD, decompression surgery was further divided into open discectomy and endoscopic discectomy.

To compare the periods before and during the COVID-19 pandemic, the patients were divided based on the date of lumbar spinal surgery. Patients who underwent surgery from January 1, 2019 to December 31, 2019 were defined as the pre-COVID-19 cohort, and patients from January 1, 2020 to December 31, 2020 as the COVID-19 cohort. The following exclusion criteria were then applied; 1) a history of spinal fracture, infection, cancer, or inflammatory arthritis; 2) previous lumbar spinal surgery; 3) missing data for sex and year of birth; 4) severe disability (class 1 or 2, ambulation was dependent on aids or a wheelchair or the patient was bedridden); and 5) under age 20 years at surgery. Finally, 78,402 patients in the pre-COVID-19 cohort and 80,165 patients in the COVID-19 cohort were included (Table 1 and Fig 2).

Table 1. Baseline characteristics.

Pre-COVID-19
(n = 78,402)
COVID-19
(n = 80,165)
p-value
Age 0.3235
Mean ± SD 59.86 ± 14.01 59.92 ± 13.99
Median [Q1, Q3] 62 [51, 70] 62 [51, 70]
Age group, n (%) < .0001
20–39 7780 (9.92) 7838 (9.78)
40–59 26741 (34.11) 26729 (33.34)
60–69 22263 (28.40) 23918 (29.84)
70–79 17356 (22.14) 17359 (21.65)
80+ 4262 (5.44) 4321 (5.39)
Sex, n (%) 0.668
Male 41172 (52.51) 42184 (52.62)
Female 37230 (47.49) 37981 (47.38)
Charlson Comorbidity index (CCI) -0.0249 < .0001
Mean ± SD 1.29 ± 1.42 1.25 ± 1.41
Median [Q1, Q3] 1 [0, 2] 1 [0, 2]
Type of insurance, n (%) 0.005
National Health Insurance 75350 (96.11) 77258 (96.37)
Medical Aid 3052 (3.89) 2907 (3.63)
Other comorbidities, n (%)
Parkinson’s disease 1111 (1.42) 1095 (1.37) 0.3849
Osteoporosis without fracture 24808 (31.64) 24778 (30.91) 0.0016
Income level, n (%) 0.0030
High (upper 20%) 26363 (33.63) 26615 (33.20)
Middle 35398 (45.15) 36851 (45.97)
Low (lower 20%) 12321 (15.72) 12535 (15.64)
National basic livelihood aid 3052 (3.89) 2907 (3.63)
Missing 1268 (1.62) 1257 (1.57)
Type of healthcare center, n (%) 0.0030
Tertiary hospital 8114 (10.35) 7890 (9.84)
General hospital 13040 (16.63) 13655 (17.03)
Primary Hospital 56072 (71.52) 57400 (71.60)
Clinic 1176 (1.50) 1220 (1.52)
Type of disease, n (%) < .0001
Spondylolysis 1135 (1.45) 1024 (1.28)
Spondylolisthesis 13682 (17.45) 14027 (17.50)
LSS 50925 (64.95) 53625 (66.89)
HIVD 12660 (16.15) 11489 (14.33)
The month of surgery, n (%) < .0001
Jan 7318 (9.33) 6915 (8.63)
Feb 5750 (7.33) 6076 (7.58)
Mar 6444 (8.22) 5785 (7.22)
Apr 6649 (8.48) 5868 (7.32)
May 6692 (8.54) 6550 (8.17)
Jun 6212 (7.92) 7245 (9.04)
Jul 7400 (9.44) 7479 (9.33)
Aug 6422 (8.19) 6701 (8.36)
Sep 6116 (7.80) 5955 (7.43)
Oct 6155 (7.85) 6885 (8.59)
Nov 6184 (7.89) 7200 (8.98)
Dec 7060 (9.00) 7506 (9.36)
Type of surgery, n (%) 0.8416
Fusion surgery 20094 (25.63) 20581 (25.67)
Decompression 58308 (74.37) 59584 (74.33)

SD, standard deviation; LSS, lumbar spinal stenosis; HIVD, herniated intervertebral disc disease

Fig 2. Flowchart of patients.

Fig 2

The number of patients corresponding to each inclusion and exclusion criteria are noted.

Variables

Age and comorbidities

Patients were categorized by age as young adults (20–39 years), middle-aged adults (40–59 years), old adults (60–69 years), seniors (70–79 years), and octogenarians or more (80–99 years). The Charlson comorbidity index (CCI) was used to assess comorbid conditions [25], and Parkinson’s disease and osteoporosis without fracture were also evaluated as other comorbidities. Comorbidities were defined on the basis of corresponding diagnoses on at least one inpatient admission or two outpatient visits within the past 2 years [2629].

Types of insurance, income, and hospitals

The types of insurance were divided into National Health Insurance and Medical Aid. The levels of income were divided into the top 20%, middle, the bottom 20%, and Medical Aid. The hospitals where surgery was performed were categorized based on their size and capacity in ROK, as tertiary referral hospitals (≥ 300 beds), general hospitals (100–300 beds), primary hospitals (30–99 beds), and clinics (30 beds) [21,22,2629].

Length of hospital stay and hospital costs

In ROK, patients usually stay in the hospital for 5–7 days after spinal surgery, but the LOH is not standardized or regulated by the insurance authorities [30]. To determine whether LOH was associated with the readmission rate, patients were subdivided into two groups (≤ 7 days and ≥ 8 days).

The hospital costs for surgery were evaluated, encompassing all expenses incurred during admission, which included cost of surgery, inpatient hospitalization, and surgical implants. The costs were converted based on the 2020 Korean Consumer Price Index (Korean Statistical Information Service Consumer Price Index. [accessed on 09 MAR 2023]; https://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1J20003&conn_path=I2) and a USD/KRW exchange rate of 1086.3 KRW/USD (Statistics Korea, [accessed on 09 MAR 2023]; https://www.index.go.kr/unity/potal/main/EachDtlPageDetail.do?idx_cd=1068). The proportions of patients were presented on a monthly basis, along with the number of COVID-19 cases. Monthly data for COVID-19 patients were obtained from the Korea Disease Control and Prevention Agency headquarters (https://ncov.kdca.go.kr/).

Discharge disposition

Discharge disposition refers to the patient’s status upon leaving the hospital, with options including either discharge to home or transfer to another medical institution. Transfer was defined as admission to another medical institution within 2 days of discharge, as direct transfer was not always possible, especially during weekends. Furthermore, the types of medical institutions to which patients were readmitted or transferred after discharge were subdivided into the following: convalescent hospitals, clinics, primary hospitals, general hospitals, tertiary referral hospitals, and oriental medicine hospitals. In ROK, convalescent hospitals function as nursing facilities.

Thirty-day readmission and reoperation

Thirty-day readmission was defined as being admitted to the same or a different medical institution within 30 days after discharge. Reoperation was defined as spine-related surgery with a diagnosis of lumbar spinal disease within 30days after the index surgery. Since the NHID does not specify the level of surgery, reoperation included surgery at either the index level or another level.

Statistical analysis

The baseline characteristics of the pre-COVID-19 and COVID-19 cohorts were presented using the mean and standard deviation, and the median and quartiles, for continuous variables. Categorical variables were presented as the number of patients and proportion. For comparisons between the cohorts, we used the chi-square test for categorical variables and the Wilcoxon rank sum test for continuous variables.

Joinpoint regression analysis was applied to examine changes in time trends of surgical cases over the first year of the COVID-19 pandemic period. This statistical method identifies the time points, called "joinpoints", where linear time trend significantly change and calculated the percentage change between trend-change points, along with the average percentage change in the entire period. The number of spinal surgeries was counted on a weekly basis from January to December 2020, and a 3-week moving average was calculated. To account for the decrease in surgical cases due to weekends or public holidays, such as Lunar New Year and Thanksgiving, the weekly number of surgical cases was adjusted based on the number of working days in those weeks. A permutation test with Monte Carlo resampling was used to determine the optimal number and location of joinpoints. The average weekly percentage change (AWPC) in the entire period was estimated as the weighted average of the estimated weekly percentage change (WPC) of each segment by utilizing the segment lengths as weights. A joinpoint regression plot, with lines connecting consecutive joinpoints, depicted the trends and shifts in data segments over the observed time period.

A logistic regression model was used to compare the rates of reoperation and readmission within 30 days after surgery between pre-COVID-19 and COVID-19 periods. For multivariate analysis, adjustments were made for age, sex, CCI, income level, length of hospital stay, Parkinson’s disease, osteoporosis, type of insurance, and type of hospital. Crude and adjusted odds ratios (ORs), along with their 95% confidence intervals, were estimated. Joinpoint regression analysis was conducted using Joinpoint Regression Program, Version 4.9.1.0 (Statistical Research and Applications Branch; National Cancer Institute, Rockville, MD, USA). The remaining statistical analyses were performed with SAS Enterprise Guide 7.1 (SAS Institute Inc, Cary, NC, USA) and R 4.2.0 (R Foundation for Statistical Computing, Vienna, Austria).

Results

The overall proportion of fusion surgery did not change during the COVID-19 pandemic (p = 0.84). However, there was a slight change in the proportion according to the diagnosis. In HIVD, the proportion of patients who underwent fusion surgery decreased (p<0.01), while the proportion of patients who underwent endoscopic discectomy increased (p<0.01). In LSS, the proportion of patients who underwent fusion surgery increased (p<0.01) (Table 2).

Table 2. Types of surgery.

Pre-COVID-19 COVID-19 p-value
All patients n = 78,402 n = 80165
Fusion surgery 20094 (25.63) 20581 (25.67) 0.8416
Decompression 58309 (74.37) 59584 (74.33)
Spondylolysis n = 1135 n = 1024
Fusion surgery 759 (66.87) 695 (67.87) 0.6212
Decompression 376 (33.13) 329 (32.13)
Spondylolisthesis n = 13682 n = 14027
Fusion surgery 9796 (71.60) 10101 (72.01) 0.4445
Decompression 3886 (28.40) 3926 (27.99)
LSS n = 50925 n = 53625
Fusion surgery 5446 (10.69) 6466 (12.06) < .0001
Decompression 45479 (89.31) 47159 (87.94)
HIVD n = 12660 n = 11489
Open discectomy 8490 (67.06) 7960 (69.28) < .0001
Endoscopic discectomy 77 (0.61) 210 (1.83) < .0001
Fusion surgery 4093 (32.33) 3319 (28.89) < .0001

LSS, lumbar spinal stenosis; HIVD, herniated intervertebral disc disease.

Number of operations and monthly distribution

The total number of operations was 78,420 in the pre-COVID-19 period and 80,165 during the COVID-19 period, indicating a slight increase in surgical procedures during the pandemic (Table 1). The majority of operations took place in primary hospitals, followed by general hospitals, tertiary hospitals, and clinics in both timeframes.

An analysis of the weekly number of operations revealed consistent patterns in both cohorts, showing declines around three major holiday seasons: the Lunar New Year, Chuseok (Korean Thanksgiving), and the Christmas-New Year holidays. Given that the Lunar New Year and Chuseok holidays are determined by the lunar calendar, the specific dates of these holidays differ annually (Fig 1A). Apart from these holiday seasons, the monthly distribution of surgeries was largely similar between the pre-COVID-19 and COVID-19 cohorts (Table 1). Notably, during the COVID-19 pandemic, there was a decline in surgeries in early March, following the first epidemic wave. This suppressed surgical volume persisted through April, and a compensatory increase in surgeries was observed by May. In August, with the onset of the second epidemic wave, there was a decrease in surgeries, but a compensatory increase occurred more quickly than after the first wave. Despite November witnessing the third and most prominent epidemic wave, there was no significant drop in surgeries or a subsequent compensatory rise. (Fig 1A)

Joinpoint regression

The five joinpoints model was selected as the best-fit model, and during the first year of COVID-19 pandemic, this model identified six segments: 1–10, 10–17, 17–32, 32–35, 35–40, and 40–51 weeks (Fig 1B). The identified first and fourth joinpoints were matched with the first and second epidemic waves. The joinpoint plot revealed a marked decline in operations up to the first joinpoint with WPC of -4.3 (p<0.01). After the first joinpoint, a compensatory increase trend with WPC 4.1 (p<0.01) was observed, up to the second joinpoint in the 17th week in April. After the second joinpoint, there was a plateau with no significant changes until the third joinpoint, at which point a declining trend emerged, with a WPC of -5.9 until the fourth joinpoint, representing the peak of the second epidemic wave. However, this decline was not statistically significant (p = 0.34). After the fourth joinpoint, the trend shifted towards an increase with a WPC of 4.1 (p<0.05) until fifth joinpoint, but then there was no further increase. Remarkably, the period corresponding to the third epidemic wave in November showed neither a decrease nor a compensatory increase (Fig 1B).

LOH and hospital costs

LOH significantly decreased by 1 day or more in patients with spondylolisthesis and HIVD. The proportion of LOH exceeding 8 days was 69.49% in the pre-COVID-19 cohort, while it decreased to 65.86% in the COVID-19 cohort (p<0.01). The mean hospital cost was significantly higher in the COVID-19 cohort than in the pre-COVID-19 cohort, across all diagnoses (from 3,511 to 4,061 USD, p < 0.01) (Table 3).

Table 3. Length of hospital stay and hospital costs during admission.

Pre-COVID-19 COVID-19 p-value
mean ± SD median [Q1, Q3] mean ± SD median [Q1, Q3]
Length of hospital stay (Day)
All patients 13 ± 10 11 [8, 16] 12 ± 8 11 [7, 15] < .0001
Spondylolysis 16 ± 9 15 [10, 19] 15 ± 9 14 [10, 19] 0.217
Spondylolisthesis 16 ± 13 15 [11, 19] 15 ± 9 14 [10, 18] < .0001
LSS 12 ± 8 10 [7, 15] 11 ± 8 10 [6, 14] < .0001
HIVD 14 ± 13 12 [8, 17] 13 ± 10 11 [8, 16] < .0001
Hospital cost (USD )*
All patients 3511 ± 2766 2687 [1810, 4329] 4061 ± 2892 3148 [2283, 5002] < .0001
Spondylolysis 4277 ± 2665 3624 [2215, 5955] 5232 ± 2823 4870 [3054, 6824] < .0001
Spondylolisthesis 5224 ± 3148 4991 [2757, 6900] 6040 ± 3251 5757 [3580, 7577] < .0001
LSS 2806 ± 2034 2370 [1607, 3341] 3356 ± 2197 2813 [2117, 3857] < .0001
HIVD 4424 ± 3651 3194 [2140, 5691] 4830 ± 3793 3508 [2508, 5917] < .0001

SD, standard deviation; LSS, lumbar spinal stenosis; HIVD, herniated intervertebral disc disease; USD, US dollar.

* Consumer price index was set at the year 2020 and the conversion of won against dollars was 1086.3.

Discharge disposition

In the pre-COVID-19 cohort, 11.25% of patients were transferred to other hospitals after discharge, while this was the case for 8.18% of patients in the COVID-19 cohort (p<0.01). A significantly higher proportion of patients with longer hospital stays were transferred to another hospital than that of patients with hospital days of 7 days or less (p<0.01 in both cohorts). The most common type of transfer location was a clinic, followed by a primary hospital, convalescent hospital, oriental medicine hospital, general hospital, tertiary hospital, and public health center. The order was the same in the pre-COVID-19 cohort, irrespective of LOH. However, in the COVID-19 cohort, the order of clinics and primary hospitals was switched (Table 4).

Table 4. Type of healthcare centers in transfers and 30-day readmissions.

Pre-COVID-19, Number of patients (%) COVID-19, Number of patients (%)
Total operation
(n = 78,402)
LOH = <7
(n = 23921, 30.5%
LOH > = 8
(n = 54481, 69.5%)
p-value Total operation
(n = 80165)
LOH = <7
(n = 27369, 34.1%)
LOH > = 8
(n = 52796, 65.9%)
p-value
Transfer to other hospitals 8822 (11.25) 1579 (6.60) 7243 (13.29) < .0001 6554 (8.18) 1287 (4.70) 5267 (9.98) < .0001
Type of healthcare center in transfer n = 8822 n = 1579 n = 7243 < .0001 n = 6554 n = 1287 n = 5267 < .0001
Convalescent hospital 1806 (20.47) 109 (6.90) 1697 (23.43) 1172 (17.88) 91 (7.07) 1081 (20.52)
Public health center 16 (0.18) 3 (0.19) 13 (0.18) 2 (0.03) 0 (0.00) 2 (0.04)
Clinic 2630 (29.81) 621 (39.33) 2009 (27.74) 1834 (27.98) 458 (35.59) 1376 (26.12)
Hospital 2353 (26.67) 502 (31.79) 1851 (25.56) 1843 (28.12) 401 (31.16) 1442 (27.38)
General hospital 916 (10.38) 191 (12.10) 725 (10.01) 573 (8.74) 145 (11.27) 428 (8.13)
Tertiary hospital 44 (0.50) 18 (1.14) 26 (0.36) 53 (0.81) 22 (1.71) 31 (0.59)
Oriental medicine hospital 1057 (11.98) 135 (8.55) 922 (12.73) 1077 (16.43) 170 (13.21) 907 (17.22)
30-day readmission 3252 (4.15) 766 (3.20) 2486 (4.56) < .0001 3036 (3.79) 853 (3.12) 2183 (4.13) < .0001
The same hospital 1366 (42.00) 159 (20.76) 1207 (48.55) < .0001 1197 (39.43) 166 (19.46) 1031 (47.23) < .0001
Other hospitals 1886 (58.00) 607 (79.24) 1279 (51.45) 1839 (60.57) 687 (80.54) 1152 (52.77)
Type of healthcare center in readmission n = 3252 n = 766 n = 2486 < .0001 n = 3036 n = 853 n = 2183 < .0001
Convalescent hospital 195 (6.00) 8 (1.04) 187 (7.52) 160 (5.27) 10 (1.17) 150 (6.87)
Public health center 4 (0.12) 0 (0.00) 4 (0.16) 0 (0.00) 0 (0.00) 0 (0.00)
Clinic 351 (10.79) 69 (9.01) 282 (11.34) 330 (10.87) 75 (8.79) 255 (11.68)
Hospital 1821 (56.00) 546 (71.28) 1275 (51.29) 1710 (56.32) 603 (70.69) 1107 (50.71)
General hospital 508 (15.62) 95 (12.40) 413 (16.61) 454 (14.95) 104 (12.19) 350 (16.03)
Tertiary hospital 121 (3.72) 27 (3.52) 94 (3.78) 111 (3.66) 39 (4.57) 72 (3.30)
Oriental medicine hospital 252 (7.75) 21 (2.74) 231 (9.29) 271 (8.93) 22 (2.58) 249 (11.41)

LOH, length of hospital stay.

Thirty-day readmission and reoperation

The 30-day readmission rate was 4.15% in the pre-COVID-19 cohort and 3.79% in the COVID-19 cohort. In both cohorts, the rates were higher in patients with longer LOH (p<0.01 in both the pre-COVID-19 and COVID-19 cohorts). Regarding readmission, in both cohorts, approximately 40% of patients were re-admitted to the same hospital, while around 60% of patients were re-admitted at other hospitals. More patients with LOH ≥ 8 days were readmitted to the same hospital (48.55% in the pre-COVID-19 cohort and 47.23% in the COVID-19 cohorts) than patients with LOH ≤ 7 days (20.76% in the pre-COVID-19 cohort [p<0.01] and 19.46% in the COVID-19 cohort [p<0.01]). The most common type of healthcare institution was primary hospitals in both the pre-COVID-19 and COVID-19 cohorts (Table 4). The reoperation rate was 0.90% in the pre-COVID-19 cohort and 0.97% in the COVID-19 cohort (Table 5). The time to reoperation was 17.28 ± 7.82 days in the pre-COVID-19 cohort and 17.11 ± 7.88 days in the COVID-19 cohort.

Table 5. Readmissions, reoperations, and transfers.

Number of patients Number of events Crude odds ratio (95% CI) p-value Adjust odds ratio* (95% CI) p-value
30-day readmission
Pre-COVID-19 78402 3252 (4.15) 1 (ref) 1 (ref)
COVID-19 80165 3036 (3.79) 0.910 (0.865,0.957) 0.0002 0.924 (0.879,0.972) 0.0023
30-day reoperation
Pre-COVID-19 78402 704 (0.90) 1 (ref) 1 (ref)
COVID-19 80165 779 (0.97) 1.083 (0.978,1.200) 0.1269 1.049 (0.946,1.162) 0.3639
Transfer to other hospital
Pre-COVID-19 78402 8822 (11.25) 1 (ref) 1 (ref)
COVID-19 80165 6554 (8.18) 0.702 (0.679,0.726) < .0001 0.715 (0.691,0.740) < .0001

* Adjusted for CCI, sex, age, income level, length of hospital stay, Parkinson’s disease, osteoporosis, type of insurance, and type of hospital.

Compared to the pre-COVID-19 period, there was a significant decrease in readmissions within 30 days and transfers to other hospitals (adjusted OR (aOR): 0.92, 95% confidence interval (CI): 0.88–0.97, p<0.01; aOR: 0.72, 95% CI: 0.69–0.74, p<0.01). However, no significant increase or decrease was observed in reoperations after surgery during this time (aOR: 1.05, 95% CI: 0.95–1.16, p = 0.36) (Table 5).

Discussion

The primary aim of our study was to investigate trends in lumbar spinal surgery during the first year of the COVID-19 pandemic in the ROK, especially in relation to specific epidemic waves. Notably, while the total number of surgeries remained stable during the pandemic, there were noticeable decrease in the monthly operation counts influenced by the early epidemic waves. These initial decreases were later balanced by an increase in surgeries in the following months. The joinpoint regression effectively captured the decline influenced by the early epidemic waves, which was then followed by a compensatory rise. Interestingly, this pattern of a decrease followed by a compensatory increase was absent during the third epidemic wave in November 2020.

After the WHO declared COVID-19 a pandemic in March 2020, most elective procedures were postponed worldwide in order to care for the unprecedented influx of critically ill patients [12,15]. Ridwan et al. reported that, in Europe, only 15% of respondents in the European Association of Neurosurgical Societies (EANS) replied that elective operations continued during April and May 2020 [31]. Blondel et al. reported that, in France, operating rooms for degenerative spine surgery operated at 20 to 50% of normal capacity, with the SFCR (The French Society of Spinal Surgery) guidelines during the early 2020 [12]. In the US, after the suspension of spinal surgery from March to June 2020, 47% of 133 patients were re-scheduled by June 2020, 16% were re-scheduled by January 2021, and 37% were ultimately not re-scheduled. Norris et al. also showed that overall, one third of patients whose surgery was suspended at the beginning of the mandatory suspension of elective surgery ultimately did not receive surgical treatment [14]. Patients with neurological dysfunction or severe symptoms were re-scheduled once the mandatory suspension of elective operations was lifted [14,32], but about 40% of patients without those problems did not undergo elective surgery.

In contrast, the situation in ROK during the first year of the pandemic showed distinct differences. First, the country experienced a relatively low number of COVID-19 cases compared to others, despite three specific epidemic waves. Second, unlike some countries, the Korean government did not implement regulatory restrictions on elective surgeries during the pandemic. Tertiary hospitals were mostly responsible for treating COVID-19 patients, allowing private hospitals to maintain their surgical volume in terms of medical resources. This redistribution may explain the decreased proportion of elective lumbar surgeries performed in tertiary hospitals during the pandemic (Table 1). Nevertheless, the unprecedented pandemic itself discouraged patients from undergoing elective surgery, particularly during the periods of specific epidemic waves.

Number of operations, monthly distribution, and epidemic waves

In ROK, three epidemic waves occurred in the first year of COVID-19 pandemic, and the peak of each wave reached on February 29th, August 27th, and December 25th, 2020. The numbers of COVID-19 patients and elective spine surgical procedures by month in 2020 showed an overall inverse correlation with the number of COVID-19 patients and the number of operations, reflecting natural response of patients and physicians to the epidemic waves. When the first wave broke out in February, the number of spinal operations decreased significantly (p<0.01). However, after April, as the number of COVID-19 patients stabilized, the number of spine operations increased again, reaching a level similar to that before COVID-19 in May and a higher level in June. In August, the second wave occurred, which was followed by a decrease in spine operations in September (p = 0.21). However, when the number of COVID-19 patients decreased after that wave, the number of spine operations then increased again in October, this time more quickly than after the first epidemic wave. Lastly, the third wave, the most serious ever, occurred in November, but there was no significant decrease in spinal surgery, unlike in the previous two waves (Fig 1).

These results demonstrate a gradual weakening of the inverse correlation between the number of COVID-19 patients and the number of elective spine operations as the pandemic progressed through multiple waves. The results of the present study may imply that the know-how obtained from past waves could have reduced patients’ concerns. Moreover, patients who initially postponed surgery due to concerns about COVID-19 infection may no longer have been able to tolerate pain or disability as the pandemic persisted [14,32,33]. This could explain the observed increase in elective spine surgery during the surge of COVID-19 cases in November and December.

The current study showed that even during the COVID-19 pandemic, total number of elective surgeries for degenerative lumbar spinal disease was maintained, despite the impact of epidemic waves. This result implies that with appropriate allocation of medical resources and medical policies, the core criteria for surgical indications and elective surgery decision-making should be unchanged. Some patients may have exhibited spontaneous improvement during the waiting period, but some may have chosen not to undergo surgery despite their disability not improving. Even those who experienced spontaneous improvement might have benefitted from surgery (e.g., less pain, potentially better neurologic recovery, etc.). Consequently, it is possible that certain patients continued to suffer from pain and disability and were unable to return to their normal lives [14,3436]. With applying surgical criteria strictly to decide the necessity of elective lumbar surgeries, essential elective surgeries could be performed. This lesson may be useful in planning policies about spine surgery and transitioning to the “new normal” era.

Changes during hospital stays

Types of surgery, LOH, and hospital costs

Overall, the distribution of surgical procedures did not substantially change. The distribution of surgical procedures for HIVD, however, saw an increase in discectomy and endoscopic discectomy, and a decrease in fusion surgery, which may suggest a pandemic-driven preference for less invasive procedures over more complex surgeries, likely due to concerns regarding extended hospital stays and postoperative care [14,3639]. Conversely, for LSS and spondylolisthesis, the proportion of fusion surgeries increased, which is inconsistent with the presumed preference toward less invasive surgery. A contributing factor may have been that the reduction in physical activity during the pandemic potentially caused exacerbating symptoms of LSS and spondylolisthesis and prompting patients to proceed with more definitive surgical interventions. The overall increase in surgeries for LSS and spondylolisthesis could also be reflective of this exacerbation. Nonetheless, since our dataset lacks detailed clinical information, the exact cause of the change remains unexplainable.

This study showed a reduced LOS during the COVID-19 pandemic. This aligns with findings from multiple studies across different types of surgery which reported a similar reduction in LOH during the pandemic, including adult spinal deformity surgery [40], elective colorectal surgery [41,42], brain tumor surgery [43], bariatric surgery [44], and partial nephrectomy [45] without compromising surgical outcomes. Several factors may have contributed to this decrease. The pandemic increased the demand for hospital beds and shortening the hospital stay was a strategy to maintain the volume of surgery [44]. Patients may have also wanted to limit their hospital stays to reduce the risk of exposure to COVID-19 [40,45]. Moreover, patients were also more willing to follow hospitals’ recommendations than before the COVID-19 pandemic [40,46]. Additionally, the increase in medical costs may have influenced the LOH. Those could be reasons for shortened LOH in countries with national health insurance systems similar to that of ROK. However, hospital costs went up despite the shortened LOH. Between 2019 and 2020, the costs of each surgical procedure increased by 10%, but hospital costs increased by approximately 16% (Table 3). This intriguing finding, however, is limited by the unavailability of detailed hospital cost data for this study. Several hypotheses could explain this, such as the expenses related to additional COVID-19 diagnostic tests, a preference for single occupancy rooms, shortages in medical resources, increased costs of goods and services, and inflation. Further research is required to pinpoint the precise reasons behind the increase in hospital costs.

Changes after discharge

Discharge disposition, readmission rate, and reoperation rate

More patients were discharged to their homes in the COVID-19 cohort. During the COVID-19 pandemic, patients and hospitals were reluctant to transfer patients to other hospitals due to concerns about cross-nosocomial infection [14,40,47,48]. This may have been a reason for the decreased proportion of hospital discharges. In both the pre-COVID-19 and COVID-19 clinics, patients were commonly transferred to primary hospitals and clinics. This finding implies that the basic roles of each hospital were maintained even during the COVID-19 pandemic. It was interesting that the shortened LOH and increased proportion of home discharges did not increase the 30-day readmission rate or the reoperation rate. The surgical technique and care protocol were similar between the pre-COVID-19 and COVID-19 cohorts, and the 1-day shorter hospital stay may not have changed the 30-day readmission rate. However, limited access to hospitals for less essential or emergent medical problems may have raised the threshold for readmission criteria. Wang et al. demonstrated that the major complication rate did not change during the COVID-19 pandemic despite shorter hospital stays [40]. Mohammed et al. also showed that complications rate did not increase during the COVID-19 pandemic [15]. However, this should not be interpreted as meaning that patients had the same conditions at discharge and during the postoperative 30-day period [46]. Pinloche et al. showed that patients had shorter stays, but were discharged with more intense pain during the COVID-19 pandemic than before [46]. Despite the similar 30-day readmission and reoperation rate, limited rehabilitation due to lockdowns may have influenced clinical outcomes [46]. Moreover, the thresholds of patients and doctors might have changed, and patients and doctors might have been reluctant to readmit patients unless their conditions were severe enough to require reoperation during the COVID-19 pandemic. Further studies with clinical data and patient satisfaction rates are required. Nonetheless, this study showed that elective spinal surgery could be continued without an increase in the readmission or reoperation rates. Maintaining the basic role of healthcare providers, while considering capacity for critical COVID-19 patients, would be helpful for patients requiring elective spinal surgery [15,40,46].

Health care system and infrastructure

The current results were obtained from data of ROK, where all people are beneficiary of national health insurance or medical aid. The access to any hospital is not limited to place, disease, and type of insurance. In the ROK, a significant majority of degenerative lumbar spine surgeries are performed in non-tertiary hospitals (approximately 90%, Table 1). Therefore, securing hospital beds for COVID-19—predominantly at tertiary hospitals—did not markedly reduce the capacity for treating patients with degenerative lumbar spinal disease. In this regard, a catch-up increase of surgeries was possible with Korean health insurance system without disrupting urgent care for the COVID-19 patients. However, the proportion of patients in each type of hospital may be different with other disease such as cancer or other complex disease. Therefore, the current idea of allowing or modifying the quota of elective surgeries may be customized based on similar analysis with each disease. In addition, the proportion of degenerative lumbar spine surgeries in large hospitals, where most of COVID-19 patients were cared, may be various according to countries and health care system. The current study showed the idea of using secondary data to make plan for contingency and it should not be a generalized plan to every disease, country and health care system.

Limitations

Although this study demonstrated the impact of the COVID-19 pandemic on lumbar degenerative disease within ROK’s national health insurance system, it had several limitations. First, the secondary data lacked information on clinical characteristics, and the exact causes of change in surgical procedures, LOH, and increased costs could not be established. The unresolved issue warrants further analysis of clinical data. In particular, changes in hospital and surgical protocols during the pandemic period could act as potential unmeasured confounders, although we were not able to identify specific changes. Second, the lessons from this study may not be generalizable because the strategies for managing the COVID-19 pandemic may have differed among countries and health care system. Nonetheless, although the specific strategies varied, the basic principle of controlling spread of infection was the same. In this regard, this study suggests that mandatory suspension of elective spinal surgery in all hospitals may not be necessary considering the specific role of each hospital according to the situation in each country. Third, during the COVID-19 pandemic, the entire world was attentive and worked together to contain the pandemic. However, such unanimous action may not be guaranteed in the future, because the knowledge gained from the COVID-19 pandemic varies among countries. Therefore, the experiences from this study may not be applicable in every situation. Despite these limitations, this study showed that ROK’s efforts to curb the COVID-19 pandemic were successful in maintaining the quality and quantity of spinal surgery. Although we have faced challenges during the COVID-19 pandemic, it is important to share the valuable lessons during these difficult times to avoid experiencing the same chaos in the future.

Conclusions

Throughout the early stages of the COVID-19 pandemic, our study observed that while elective lumbar spinal surgeries were initially disrupted by pandemic and epidemic waves, they subsequently experienced a compensatory increase, indicating that surgical care adapted to the pandemic’s challenges. This adaptability, alongside the stable total number of operations, highlights the potential for healthcare systems to continue essential surgical services during public health crises with strategic resource allocation and patient triage. As we consider the indirect effects of the pandemic on hospital length of stay, discharge dispositions, costs, and readmission rates, these insights underscore the importance of developing robust, flexible healthcare policies for clinicians, researchers, and healthcare policy makers. Such policies should ensure that elective spinal surgeries, especially those not requiring urgent care but crucial for patient quality of life, are not unnecessarily halted. Although circumstances vary from country to country, making it difficult to generalize these findings universally, the valuable lessons learned from the challenges of the COVID-19 pandemic should be used as a guide for future strategies in managing similar health crises.

Acknowledgments

The authors appreciate the statistical advice provided by the Medical Research Collaborating Center at Seoul National University Hospital.

Data Availability

In the Republic of Korea (ROK), nearly all residents are beneficiaries of the national health insurance system (NHIS), and all nationwide inpatient and outpatient data regarding diseases and services (i.e., procedures and operations) are coded and registered in the National Health Information Database (NHID) and the Health Insurance Review & Assessment Service (HIRA) database, thus enabling population-based studies to be conducted. The NHID contains demographic characteristics and insurance eligibility information, as well as data on almost all hospitalizations and outpatient medical services. This information encompasses diagnoses, which are based on International Classification of Diseases 10th Revision codes, procedures, prescriptions, examinations, and direct medical costs. We assert that there were no special privileges accorded to the authors in accessing the NHID data. The process followed adheres strictly to the standard protocol provided by NHIS, ensuring equal opportunity for data access to all researchers. The NHIS-NHID data is available to any researchers who are interested by following the appropriate request and review process outlined on the NHIS website (https://nhiss.nhis.or.kr/bd/ab/bdaba032eng.do). There is a cost for the assess to the NHID and the use of virtual terminal.

Funding Statement

This study was supported by Seoul National University Hospital Research Fund (Grant No. 3020230120), Doosan Yonkang Foundation (Grant No. 800-20210527), and Armed Forces Capital Hospital (Grant No. 2023MDD0075), received by Chi Heon Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.

References

  • 1.Lee SW, Yuh WT, Yang JM, Cho YS, Yoo IK, Koh HY, et al. Nationwide Results of COVID-19 Contact Tracing in South Korea: Individual Participant Data From an Epidemiological Survey. JMIR Med Inform. 2020;8(8):e20992. Epub 20200825. doi: 10.2196/20992 ; PubMed Central PMCID: PMC7470235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bose SK, Dasani S, Roberts SE, Wirtalla C, DeMatteo RP, Doherty GM, et al. The Cost of Quarantine: Projecting the Financial Impact of Canceled Elective Surgery on the Nation’s Hospitals. Ann Surg. 2021;273(5):844–9. doi: 10.1097/SLA.0000000000004766 . [DOI] [PubMed] [Google Scholar]
  • 3.Michel CR, Dijanic C, Sudah S, Kerrigan D, Cohen J. Has Public Interest in Elective Spine Surgery Returned to Pre-COVID 19 Levels? A Google Trends Analysis. Cureus. 2022;14(3):e22858. Epub 20220304. doi: 10.7759/cureus.22858 ; PubMed Central PMCID: PMC8977504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zeng X. Conducting Research During the COVID-19 Pandemic: How Scientific Community Should be Prepared? Neurospine. 2020;17(2):351–3. Epub 20200518. doi: 10.14245/ns.2040212.106 ; PubMed Central PMCID: PMC7338958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wang B. The Role of Spine Surgeons in the Era of COVID-19 Outbreak. Neurospine. 2020;17(2):342–3. Epub 20200518. doi: 10.14245/ns.2040206.103 ; PubMed Central PMCID: PMC7338950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Stienen MN. COVID-19 in Europe: Le roi est mort, vive le roi! Neurospine. 2020;17(2):344–7. Epub 20200518. doi: 10.14245/ns.2040202.105 ; PubMed Central PMCID: PMC7338967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Sayari AJ, Harada GK, Louie PK, McCarthy MH, Nolte MT, Mallow GM, et al. Personal Health of Spine Surgeons Can Impact Perceptions, Decision-Making and Healthcare Delivery During the COVID-19 Pandemic—A Worldwide Study. Neurospine. 2020;17(2):313–30. Epub 20200630. doi: 10.14245/ns.2040336.168 ; PubMed Central PMCID: PMC7338966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Park KB, Kanmounye US, Lartigue JW. Global Neurosurgery in the Time of COVID-19. Neurospine. 2020;17(2):348–50. Epub 20200518. doi: 10.14245/ns.2040246.123 ; PubMed Central PMCID: PMC7338951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jain NS, Wang JC. COVID-19 and the Role of Spine Surgeons. Neurospine. 2020;17(2):331–3. Epub 20200518. doi: 10.14245/ns.2040202.101 ; PubMed Central PMCID: PMC7338949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Cho DC. In the Era of COVID-19: The Role of Spine Surgeons at the Epicenter of the Outbreak. Neurospine. 2020;17(2):337–8. Epub 20200518. doi: 10.14245/ns.2040244.122 ; PubMed Central PMCID: PMC7338944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Brembilla C, Veiceschi P, Fanti A, Costi E, Passoni M, Sicignano AM, et al. The Eclipse of Degenerative Spine Pathology During COVID-19 Pandemic. Neurospine. 2020;17(2):354–6. Epub 20200518. doi: 10.14245/ns.2040268.134 ; PubMed Central PMCID: PMC7338948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Blondel B, Prost S, Chaussemy D, Mohsinaly Y, Ghailane S, Pascal-Moussellard H, et al. How was spinal surgery activity maintained during the COVID-19 pandemic? Results of a French multicenter observational study. Orthop Traumatol Surg Res. 2022:103221. Epub 20220127. doi: 10.1016/j.otsr.2022.103221 ; PubMed Central PMCID: PMC8801597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Soffin EM, Reisener MJ, Sama AA, Beckman JD, Liguori GA, Lebl DR, et al. Essential Spine Surgery During the COVID-19 Pandemic: A Comprehensive Framework for Clinical Practice from a Specialty Orthopedic Hospital in New York City. HSS J. 2020;16(Suppl 1):29–35. Epub 20200910. doi: 10.1007/s11420-020-09786-0 ; PubMed Central PMCID: PMC7482371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Norris ZA, Sissman E, O’Connell BK, Mottole NA, Patel H, Balouch E, et al. COVID-19 pandemic and elective spinal surgery cancelations—what happens to the patients? Spine J. 2021;21(12):2003–9. Epub 20210730. doi: 10.1016/j.spinee.2021.07.019 ; PubMed Central PMCID: PMC8321964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mohammed R, Shah P, Durst A, Mathai NJ, Budu A, Woodfield J, et al. Restoration of elective spine surgery during the first wave of COVID-19: a UK-wide British Association of Spine Surgeons (BASS) prospective, multicentre, observational study. Bone Jt Open. 2021;2(12):1096–101. doi: 10.1302/2633-1462.212.BJO-2021-0116.R1 ; PubMed Central PMCID: PMC8711666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Arnold PM, Owens L, Heary RF, Webb AG, Whiting MD, Vaccaro AR, et al. Lumbar Spine Surgery and What We Lost in the Era of the Coronavirus Pandemic: A Survey of the Lumbar Spine Research Society. Clin Spine Surg. 2021;34(10):E575–E9. doi: 10.1097/BSD.0000000000001235 ; PubMed Central PMCID: PMC8628851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Jain NS, Alluri RK, Schopler SS, Hah R, Wang JC. COVID-19 and Spine Surgery: A Review and Evolving Recommendations. Global Spine J. 2020;10(5):528–33. Epub 20200423. doi: 10.1177/2192568220923655 ; PubMed Central PMCID: PMC7359679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Mehta AI, Chiu RG. COVID-19 Nonessential Surgery Restrictions and Spine Surgery: A German Experience. Spine (Phila Pa 1976). 2020;45(14):942–3. doi: 10.1097/BRS.0000000000003571 ; PubMed Central PMCID: PMC7299108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Meyer M, Prost S, Farah K, Denis JB, Dufour H, Blondel B, et al. Spine Surgical Procedures during Coronavirus Disease 2019 Pandemic: Is It Still Possible to Take Care of Patients? Results of an Observational Study in the First Month of Confinement. Asian Spine J. 2020;14(3):336–40. Epub 20200508. doi: 10.31616/asj.2020.0197 ; PubMed Central PMCID: PMC7280921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kim CH, Chung CK, Choi Y, Shin S, Kim MJ, Lee J, et al. The Selection of Open or Percutaneous Endoscopic Lumbar Discectomy According to an Age Cut-off Point: Nationwide Cohort Study. Spine (Phila Pa 1976). 2015;40(19):E1063–70. doi: 10.1097/BRS.0000000000001053 . [DOI] [PubMed] [Google Scholar]
  • 21.Kim CH, Chung CK, Park CS, Choi B, Hahn S, Kim MJ, et al. Reoperation rate after surgery for lumbar spinal stenosis without spondylolisthesis: a nationwide cohort study. Spine J. 2013;13(10):1230–7. Epub 2013/09/11. doi: 10.1016/j.spinee.2013.06.069 . [DOI] [PubMed] [Google Scholar]
  • 22.Kim CH, Chung CK, Park CS, Choi B, Kim MJ, Park BJ. Reoperation rate after surgery for lumbar herniated intervertebral disc disease: nationwide cohort study. Spine (Phila Pa 1976). 2013;38(7):581–90. doi: 10.1097/BRS.0b013e318274f9a7 . [DOI] [PubMed] [Google Scholar]
  • 23.Salyer SJ, Maeda J, Sembuche S, Kebede Y, Tshangela A, Moussif M, et al. The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study. Lancet. 2021;397(10281):1265–75. Epub 20210324. doi: 10.1016/S0140-6736(21)00632-2 ; PubMed Central PMCID: PMC8046510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Martin BI, Lurie JD, Tosteson AN, Deyo RA, Tosteson TD, Weinstein JN, et al. Indications for spine surgery: validation of an administrative coding algorithm to classify degenerative diagnoses. Spine (Phila Pa 1976). 2014;39(9):769–79. doi: 10.1097/BRS.0000000000000275 ; PubMed Central PMCID: PMC4018409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Glasheen WP, Cordier T, Gumpina R, Haugh G, Davis J, Renda A. Charlson Comorbidity Index: ICD-9 Update and ICD-10 Translation. Am Health Drug Benefits. 2019;12(4):188–97. ; PubMed Central PMCID: PMC6684052. [PMC free article] [PubMed] [Google Scholar]
  • 26.Jung JM, Chung CK, Kim CH, Choi Y, Kim MJ, Yim D, et al. The Long-term Reoperation Rate Following Surgery for Lumbar Stenosis: A Nationwide Sample Cohort Study With a 10-year Follow-up. Spine (Phila Pa 1976). 2020;45(18):1277–84. doi: 10.1097/BRS.0000000000003515 . [DOI] [PubMed] [Google Scholar]
  • 27.Kim CH, Chung CK, Choi Y, Kim MJ, Kim MJ, Shin S, et al. Increased Proportion of Fusion Surgery for Degenerative Lumbar Spondylolisthesis and Changes in Reoperation Rate: A Nationwide Cohort Study With a Minimum 5-Year Follow-up. Spine (Phila Pa 1976). 2019;44(5):346–54. Epub 2018/07/22. doi: 10.1097/BRS.0000000000002805 . [DOI] [PubMed] [Google Scholar]
  • 28.Kim CH, Chung CK, Choi Y, Kim MJ, Yim D, Yang SH, et al. The Long-term Reoperation Rate Following Surgery for Lumbar Herniated Intervertebral Disc Disease: A Nationwide Sample Cohort Study With a 10-year Follow-up. Spine (Phila Pa 1976). 2019;44(19):1382–9. doi: 10.1097/BRS.0000000000003065 . [DOI] [PubMed] [Google Scholar]
  • 29.Kim CH, Chung CK, Choi Y, Lee J, Yang SH, Lee CH, et al. Direct medical costs after surgical or nonsurgical treatment for degenerative lumbar spinal disease: A nationwide matched cohort study with a 10-year follow-up. PLoS One. 2021;16(12):e0260460. Epub 20211201. doi: 10.1371/journal.pone.0260460 ; PubMed Central PMCID: PMC8635587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kim JH, Lee EH, Kim SR, Kim SR. Factors Affecting Discharge Delay in Lumbar Spinal Surgery Patients who were Treated according to a Critical Pathway. Korean Journal of Adult Nursing. 2016;28(1). [Google Scholar]
  • 31.Ridwan S, Ganau M, Zoia C, Broekman M, Grote A, Clusmann H. Unequal Impact of COVID-19 on Private and Academic Neurosurgical Workforce: Results of an International Survey. Front Surg. 2021;8:749399. Epub 20211001. doi: 10.3389/fsurg.2021.749399 ; PubMed Central PMCID: PMC8517237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wilson JM, Schwartz AM, Grissom HE, Holmes JS, Farley KX, Bradbury TL, et al. Patient Perceptions of COVID-19-Related Surgical Delay: An Analysis of Patients Awaiting Total Hip and Knee Arthroplasty. HSS J. 2020;16(Suppl 1):45–51. Epub 20200915. doi: 10.1007/s11420-020-09799-9 ; PubMed Central PMCID: PMC7491018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Park SJ, Hwang JM, Cho DC, Lee S, Kim CH, Han I, et al. Indirect Decompression Using Oblique Lumbar Interbody Fusion Revision Surgery Following Previous Posterior Decompression: Comparison of Clinical and Radiologic Outcomes Between Direct and Indirect Decompression Revision Surgery. Neurospine. 2022;19(3):544–54. Epub 20220930. doi: 10.14245/ns.2244242.121 ; PubMed Central PMCID: PMC9537844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Wu PH, Lau ET, Kim HS, Grasso G, Jang IT. Spinal Canal Remodeling and Indirect Decompression of Contralateral Foraminal Stenosis After Endoscopic Posterolateral Transforaminal Lumbar Interbody Fusion. Neurospine. 2023;20(1):99–109. Epub 20230331. doi: 10.14245/ns.2346132.066 ; PubMed Central PMCID: PMC10080438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Noh SH, Lee HS, Park GE, Ha Y, Park JY, Kuh SU, et al. Predicting Mechanical Complications After Adult Spinal Deformity Operation Using a Machine Learning Based on Modified Global Alignment and Proportion Scoring With Body Mass Index and Bone Mineral Density. Neurospine. 2023;20(1):265–74. Epub 20230331. doi: 10.14245/ns.2244854.427 ; PubMed Central PMCID: PMC10080453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kassicieh AJ, Rumalla K, Segura AC, Kazim SF, Vellek J, Schmidt MH, et al. Endoscopic and Nonendoscopic Approaches to Single-Level Lumbar Spine Decompression: Propensity Score-Matched Comparative Analysis and Frailty-Driven Predictive Model. Neurospine. 2023;20(1):119–28. Epub 20230331. doi: 10.14245/ns.2346110.055 ; PubMed Central PMCID: PMC10080425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kwon H, Park JY. The Role and Future of Endoscopic Spine Surgery: A Narrative Review. Neurospine. 2023;20(1):43–55. Epub 20230331. doi: 10.14245/ns.2346236.118 ; PubMed Central PMCID: PMC10080412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ju CI, Lee SM. Complications and Management of Endoscopic Spinal Surgery. Neurospine. 2023;20(1):56–77. Epub 20230331. doi: 10.14245/ns.2346226.113 ; PubMed Central PMCID: PMC10080410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Chen KT, Kim JS, Huang AP, Lin MH, Chen CM. Current Indications for Spinal Endoscopic Surgery and Potential for Future Expansion. Neurospine. 2023;20(1):33–42. Epub 20230331. doi: 10.14245/ns.2346190.095 ; PubMed Central PMCID: PMC10080449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Wang KY, McNeely EL, Dhanjani SA, Raad M, Puvanesarajah V, Neuman BJ, et al. COVID-19 Significantly Impacted Hospital Length of Stay and Discharge Patterns for Adult Spinal Deformity Patients. Spine (Phila Pa 1976). 2021;46(22):1551–6. doi: 10.1097/BRS.0000000000004204 ; PubMed Central PMCID: PMC8552912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Spinelli A, Carvello M, Carrano FM, Pasini F, Foppa C, Taffurelli G, et al. Reduced duration of stay after elective colorectal surgery during the peak phase of COVID-19 pandemic: A positive effect of infection risk awareness? Surgery. 2021;170(2):558–62. doi: 10.1016/j.surg.2020.12.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Feier CVI, Bardan R, Muntean C, Olariu A, Olariu S. Impact of the COVID-19 Pandemic on the Elective Surgery for Colorectal Cancer: Lessons to Be Learned. Medicina (Kaunas). 2022;58(10). Epub 20220921. doi: 10.3390/medicina58101322 ; PubMed Central PMCID: PMC9609708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Mallari RJ, Avery MB, Corlin A, Eisenberg A, Hammond TC, Martin NA, et al. Streamlining brain tumor surgery care during the COVID-19 pandemic: A case-control study. PLOS ONE. 2021;16(7):e0254958. doi: 10.1371/journal.pone.0254958 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Verhoeff K, Mocanu V, Dang J, Wilson H, Switzer NJ, Birch DW, et al. Effect of the COVID-19 pandemic on bariatric surgery in North America: a retrospective analysis of 834,647 patients. Surg Obes Relat Dis. 2022;18(6):803–11. Epub 20220319. doi: 10.1016/j.soard.2022.03.012 ; PubMed Central PMCID: PMC8933967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Chun B, Ramian H, Jones C, Vasan R, Yabes JG, Davies BJ, et al. Changes in Urologic Cancer Surgical Volume and Length of Stay During the COVID-19 Pandemic in Pennsylvania. JAMA Network Open. 2023;6(4):e239848-e. doi: 10.1001/jamanetworkopen.2023.9848 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Pinloche L, Souvignet S, Germain M, Monteil K, Hautier C. The short-term effect of a myofascial protocol versus light touch applied to the cervical spine towards the prevention of balance disorders in the elderly: protocol of a randomised controlled trial. Chiropr Man Therap. 2022;30(1):33. Epub 20220831. doi: 10.1186/s12998-022-00446-0 ; PubMed Central PMCID: PMC9429471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Rana K, Sharma B, Lakshmi PVM, Kaur M, Singh MP, Singh R, et al. Nosocomial Outbreak of SARS-CoV-2 in a Non-COVID Zone of a Tertiary Care Hospital of North India: Need to Upgrade Infection Control Practices. J Prim Care Community Health. 2021;12:21501327211050753. doi: 10.1177/21501327211050753 ; PubMed Central PMCID: PMC8669871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Lakhani K, Minguell J, Guerra-Farfan E, Lara Y, Jambrina U, Pijoan J, et al. Nosocomial infection with SARS-CoV-2 and main outcomes after surgery within an orthopaedic surgery department in a tertiary trauma centre in Spain. Int Orthop. 2020;44(12):2505–13. Epub 20200911. doi: 10.1007/s00264-020-04798-1 ; PubMed Central PMCID: PMC7483069. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Kentaro Yamada

29 Feb 2024

PONE-D-23-41698Trends in degenerative lumbar spinal surgery during the early COVID-19 pandemic in Republic of Korea: a national study utilizing the National Health Insurance DatabasePLOS ONE

Dear Dr. Kim,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Kentaro Yamada, M.D., Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating in your Funding Statement: 

This study was supported by Seoul National University Hospital Research Fund (Grant No. 3020230120), Doosan Yonkang Foundation (Grant No. 800-20210527), and Armed Forces Capital Hospital (Grant No. 2023MDD0075), received by Chi Heon Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Please provide an amended statement that declares all the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. 

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for submitting this interesting and informative manuscript to PLoS One. I was pleased to receive it as a reviewer.

While your manuscript provides valuable insights into an important healthcare topic, there are a few areas that could be refined to further augment the quality and impact of the work. Here are some respectful suggestions that could potentially improve the paper if you choose to implement them:

Abstract

- The abstract clearly summarizes key aspects, but the conclusion may be strengthened by elaborating on the practice-relevant implications regarding elective surgery policies during pandemics.

Introduction

- The introduction effectively covers the background of the study. As the discussion notes study limitations regarding generalizability, the introduction could benefit from briefly mentioning upfront that the healthcare infrastructure and pandemic responses likely differ across countries.

- Consider further elaborating on the rationale for focusing specifically on degenerative lumbar spinal diseases and surgeries. For example, you could explain if patients with these conditions could be more vulnerable during pandemics versus other spine issues.

Methods

- The methods are detailed overall. As a suggestion, it could be useful to state if there were any changes to hospital or surgical protocols between the cohorts that could have impacted the results through unmeasured confounders.

- Consider providing more details on the propensity score matching process. Which specific variables were included and why? How was the greedy matching algorithm optimized?

- Consider explaining the rationale for replacing surgery numbers for holiday weeks with average values. Elaborate on assumptions and implications.

Results

- When presenting the changes in proportions of surgery types for the diagnoses, consider speculating on potential reasons driving the shifts. This would give readers more context when interpreting the results.

Discussion

- The discussion provides meaningful interpretation of results and balances the strengths against limitations. To augment the actionability of the conclusions, you could elaborate further on the presumed practice-relevant implications regarding elective surgery decisions during pandemics.

- Compare and contrast findings with other COVID-19-era studies on spine surgery trends from different countries to put results into perspective. How and why are they similar or different?

- Discuss the degree to which the conclusions can be reasonably extrapolated to healthcare systems with differing infrastructure and pandemic responses compared to the Republic of Korea population.

Conclusions

- The conclusions concisely summarize the main outcomes. To amplify the impact, you may consider incorporating more specific guidance regarding elective spine surgery policies during future public health emergencies based on your findings.

Overall, these suggestions aim to enhance the manuscript's overall quality for clinicians, researchers, and healthcare policy makers. I believe that implementing the above suggestions would make your important work more useful for informing practice under crisis situations.

Reviewer #2: Thank you for the opportunity to review the paper by Kim and colleagues regarding a study on the status of spinal surgery during the COVID-19 pandemic in South Korea using real-world data. This is a well-written manuscript and offers valuable societal insights. I read this manuscript with great interest. While I respect the authors' significant effort in extracting detailed information from nationwide population-based data, there are several methodological problems with this study.

Major Comments:

1. The utilization of propensity score matching as a method in this study appears inappropriate, given the assumptions associated with this technique. If the intention is to compare pre- and post-population, I would recommend employing regression adjustment incorporating variables pertinent to the outcome of interest. As alternative methods, standardization methods such as Standardized Mortality Ratios (SMR) could be considered.

2. Overall, the paper is redundant in its description. For example, the "patient inclusion" and "variables" sections have room for improvement.

3. (Page 7, line 157-) Although many populations have been excluded, these exclusions may be inappropriate when examining trends in the number of surgeries.

4. (Page 15, line 253-) In applying joinpoint regression, the authors appear to have corrected the data, but I cannot determine if this is appropriate. I'm afraid this data handling may affect the results.

Minor comments

1. Many studies have pointed to a decrease in postoperative hospital stay for various surgeries. Consider citing these.

2. (Table 1) The column of CCI is broken; please correct it.

Finally, I would like to express my respect for the great effort of the authors in this paper. I hope this paper will be properly revised and published.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Savvas Lampridis

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jun 11;19(6):e0305128. doi: 10.1371/journal.pone.0305128.r002

Author response to Decision Letter 0


15 Apr 2024

Reviewer #1

Comment - Thank you for submitting this interesting and informative manuscript to PLOS ONE. I was pleased to receive it as a reviewer.

Authors’ response:

Thank you for your time and effort to review our manuscript. We truly appreciate your valuable comments.

Comment - While your manuscript provides valuable insights into an important healthcare topic, there are a few areas that could be refined to further augment the quality and impact of the work. Here are some respectful suggestions that could potentially improve the paper if you choose to implement them:

Authors’ response:

We are thankful for your insightful comments, which have significantly contributed to the enhancement of our manuscript, particularly in areas concerning healthcare system and infrastructure, policies across different countries, clinical implications, and future healthcare crisis strategy. We wholeheartedly agree with your perspective. It was indeed a great pleasure to revise our manuscript in line with your valuable suggestions, and we hope that our revisions will fulfill your expectations and meet the standards for publication.

Abstract

Comment #1 - The abstract clearly summarizes key aspects, but the conclusion may be strengthened by elaborating on the practice-relevant implications regarding elective surgery policies during pandemics.

Authors’ response:

Thank you for your constructive feedback on our abstract. We appreciate your suggestion to elaborate on the practice-relevant implications of elective surgery policies during pandemics. During the pandemic, COVID-19 patients were primarily treated in tertiary hospitals, allowing lumbar surgeries to proceed with minimal disruption in other types of healthcare facilities. This pattern, while not initially a strategic approach, demonstrated an effective allocation of medical resources under the national health insurance system. These findings, emerging from the challenges posed by the pandemic, offer valuable insights for future planning. Employing such a triage approach could serve as a deliberate strategy in managing elective surgeries during future health crises. In our revised conclusion, we have highlighted the observed effect, which acted like a natural triage system.

Change to Text:

[Abstract, Page 3, Line 63-69]

Despite the impact of epidemic waves on monthly surgery numbers, a subsequent compensatory increase was observed, indicating that surgical care has adapted to the challenges of the pandemic. This adaptability, along with the stable total number of operations, highlights the potential for healthcare systems to continue elective spine surgery during public health crises with strategic resource allocation and patient triage. Policies should ensure that surgeries for degenerative spinal diseases, particularly those not requiring urgent care but crucial for patient quality of life, are not unnecessarily halted.

Introduction

Comment #2 - The introduction effectively covers the background of the study. As the discussion notes study limitations regarding generalizability, the introduction could benefit from briefly mentioning upfront that the healthcare infrastructure and pandemic responses likely differ across countries.

Authors’ response:

Thank you for your comment regarding the need to clarify the context of healthcare infrastructure and pandemic responses across countries. We acknowledge that our findings are specific to the ROK's healthcare system, which is characterized by universal coverage through national health insurance and medical aid. We have included a brief mention of the ROK's healthcare infrastructure, which, while not universally applicable, serves as a conceptual framework for planning in diverse healthcare systems. We also have included the distinct pandemic response of ROK, different from other countries.

Change to Text:

[Introduction, Page 4, Line 81-89]

While the main guidelines and strategies in every country were similar, the healthcare infrastructure and pandemic responses, including spinal surgery varied among countries. [12, 13] For example, in ROK, all people are beneficiary of national health insurance or medical aid, and the access to any hospital is not limited to place. During the COVID-19 pandemic, the government of ROK did not restrict elective surgical procedures officially. On the other hand, in the USA, the COVID-19 pandemic led to a nationwide suspension of elective surgery, including spinal procedures, from March 2020 to May 2020.[14] the COVID-19 pandemic led to a nationwide suspension of elective surgery, including spinal procedures, from March 2020 to May 2020.[14]

Although the government of ROK did not officially restrict elective spinal surgeries during the pandemic, the conditions for such surgeries changed significantly.

Comment #3 - Consider further elaborating on the rationale for focusing specifically on degenerative lumbar spinal diseases and surgeries. For example, you could explain if patients with these conditions could be more vulnerable during pandemics versus other spine issues.

Authors’ response:

We are grateful for the opportunity to clearly explain the focus of our study on degenerative lumbar spinal diseases and surgeries. As briefly mentioned in the introduction part of the original manuscript, degenerative lumbar surgeries are performed not for treating an immediate threat to life, but for improving patients’ quality of life, by alleviating pain and functional impairment. However, during a pandemic, when medical priorities shift towards acute critical care for COVID-19 patients, these lumbar elective surgeries are prone to delays or cancellations, consequently rendering them significantly vulnerable. Even compared to other spine issues, such as cervical or thoracic spinal disease, or spinal trauma, the medical priority of degenerative lumbar disease is low. While postponements may seem appropriate considering the short-term urgency of a pandemic, they can cause increased suffering for patients with degenerative spine issues as the pandemic becomes protracted, even if their conditions are not directly life-threatening. We have further elaborated on these aspects in the introduction part as suggested by the reviewer.

Change to Text:

[Introduction, Page 5, Line 99-109]

Surgical interventions for degenerative lumbar spinal disease are typically elective and focused on enhancing quality of life rather than addressing emergencies that threaten life immediately. As a result, these conditions are often assigned a lower priority compared to other spinal diseases such as cervical or thoracic lesions with neurological deficits or spinal traumas requiring urgent surgical interventions. In the initial stages of the COVID-19 pandemic, elective surgeries for degenerative lumbar diseases were frequently deferred or canceled as medical priorities shifted to pandemic management. This practice, although intended to conserve medical resources for acute pandemic care, was found to potentially worsen the long-term quality of life of these patients, increasing their vulnerability as the pandemic protracted. [12, 14-19] Based on this experience, this study was designed to observe the impact of the COVID-19 pandemic on surgeries for patients with degenerative lumbar spinal disease who are vulnerable during pandemics.

Methods

Comment #4 - The methods are detailed overall. As a suggestion, it could be useful to state if there were any changes to hospital or surgical protocols between the cohorts that could have impacted the results through unmeasured confounders.

Authors’ response:

Thank you for your comment regarding the potential impact of changes in hospital or surgical protocols on our results. We analyzed the NHID customized data, representing a claim dataset of entire national population. Although it lacks detailed clinical data, our objective was to examine the trends of elective lumbar surgery influenced by numerous COVID-19 pandemic-related factors, including any modifications to hospital or surgical protocols. We specifically looked for changes in hospital or surgical protocols unrelated to the COVID-19 pandemic that could serve as significant confounders. However, we couldn’t find any protocol change between the cohorts during the study period that would qualify as unmeasured confounders separate from those associated with the COVID-19 pandemic. We have acknowledged this in the limitations, noting the potential for confounders related to changes in hospital and surgical protocols, although we were not able to identify specific changes. Again, thank you for raising an important question.

Change to Text:

[Limitation, Page 25, Line 483-487]

First, the secondary data lacked information on clinical characteristics, and the exact causes of change in surgical procedures, LOH, and increased costs could not be established. The unresolved issue warrants further analysis of clinical data. In particular, changes in hospital and surgical protocols during the pandemic period could act as potential unmeasured confounders, although we were not able to identify specific changes.

Comment #5 - Consider providing more details on the propensity score matching process. Which specific variables were included and why? How was the greedy matching algorithm optimized?

Authors’ response:

Thank you for your question concerning the details of the propensity score matching process. Initially, our model employed propensity score matching to compare the pre- and post-COVID-19 cohorts. However, based on the reviewers' feedback, highlighting concerns about the appropriateness of the propensity score matching, and on suggestion from another reviewer, we decided to change our comparison approach to linear regression in the whole population with multivariable adjustment. This revised method could be more suitable for comparison between the pre-COVID-19 and COVID-19 periods while enabling us to effectively control for potential confounders. We believe that this modification better aligns with the study's objectives.

Change to Text:

[Materials and methods, Page 13, Line 246-250]

A logistic regression model was used to compare the rates of reoperation and readmission within 30 days after surgery between pre-COVID-19 and COVID-19 periods. For multivariate analysis, adjustments were made for age, sex, CCI, income level, length of hospital stay, Parkinson’s disease, osteoporosis, type of insurance, and type of hospital. Crude and adjusted odds ratios (ORs), along with their 95% confidence intervals, were estimated.

Comment #6 - Consider explaining the rationale for replacing surgery numbers for holiday weeks with average values. Elaborate on assumptions and implications.

Authors’ response:

Thank you for your comment. Our rationale for initially replacing surgery numbers during holiday weeks with average values was to minimize the impact of reduced medical service utilization during the Lunar New Year and Thanksgiving. In Korea, these holidays are traditionally accompanied by at least four consecutive days off, and it's common for people to avoid scheduling elective surgeries during these times. However, acknowledging your concern about how this approach might affect the results, we revised our methodology. We no longer replace surgery numbers for holiday weeks with average values; instead, we adjust the weekly number of surgeries by working day. This adjustment would provide a more accurate reflection of surgical activity during these periods without altering the data.

Change to Text:

[Materials and methods, Page 12, Line 233-240]

Joinpoint regression analysis was applied to examine changes in time trends of surgical cases over the first year of the COVID-19 pandemic period. This statistical method identifies the time points, called "joinpoints", where linear time trend significantly change and calculated the percentage change between trend-change points, along with the average percentage change in the entire period. The number of spinal surgeries was counted on a weekly basis from January to December 2020, and a 3-week moving average was calculated. To account for the decrease in surgical cases due to weekends or public holidays, such as Lunar New Year and Thanksgiving, the weekly number of surgical cases was adjusted based on the number of working days in those weeks.

Results

Comment #7 - When presenting the changes in proportions of surgery types for the diagnoses, consider speculating on potential reasons driving the shifts. This would give readers more context when interpreting the results.

Authors’ response:

Thank you for your valuable comment. In the discussion section of our manuscript, we have briefly mentioned the potential reasons for the shifts in surgery types. Overall, the distribution of surgical procedures did not substantially change. The distribution of surgical procedures for HIVD, however, saw an increase in discectomy and endoscopic discectomy, and a decrease in fusion surgery, which may suggest a pandemic-driven preference for less invasive procedures over more complex surgeries, likely due to concerns regarding extended hospital stays and postoperative care.

Conversely, for LSS and spondylolisthesis, the proportion of fusion surgeries increased, which is inconsistent with the presumed preference toward less invasive surgery. A contributing factor may have been that the reduction in physical activity during the pandemic potentially caused exacerbating symptoms of LSS and spondylolisthesis and prompting patients to proceed with more definitive surgical interventions. The overall increase in surgeries for LSS and spondylolisthesis could also be reflective of this exacerbation. Nonetheless, our dataset lacks detailed clinical information to explain the exact causes of these shifts. Hence, while we can offer plausible hypotheses, the precise reasons for the changes in surgical trends remain elusive. We have included this context in the discussion part.

Change to Text:

[Discussion, Page 22, Line 409-419]

Overall, the distribution of surgical procedures did not substantially change. The distribution of surgical procedures for HIVD, however, saw an increase in discectomy and endoscopic discectomy, and a decrease in fusion surgery, which may suggest a pandemic-driven preference for less invasive procedures over more complex surgeries, likely due to concerns regarding extended hospital stays and postoperative care.[14, 36-39] Conversely, for LSS and spondylolisthesis, the proportion of fusion surgeries increased, which is inconsistent with the presumed preference toward less invasive surgery. A contributing factor may have been that the reduction in physical activity during the pandemic potentially caused exacerbating symptoms of LSS and spondylolisthesis and prompting patients to proceed with more definitive surgical interventions. The overall increase in surgeries for LSS and spondylolisthesis could also be reflective of this exacerbation. Nonetheless, since our dataset lacks detailed clinical information, the exact cause of the change remains unexplainable.

Discussion

Comment #8 - The discussion provides meaningful interpretation of results and balances the strengths against limitations. To augment the actionability of the conclusions, you could elaborate further on the presumed practice-relevant implications regarding elective surgery decisions during pandemics.

Authors’ response:

Thank you for your insightful suggestion. We recognize that the core criteria for surgical indications and elective surgery decision-making remain unchanged, while the allocation of medical resources and patients' attitudes toward elective surgery become critical in a pandemic setting. We advocate for the application of strict surgical criteria to decide the necessity of elective lumbar surgeries, thereby ensuring that only essential surgeries are performed. This approach should take into account the available medical resources to prioritize effectively among all patients, including those with COVID-19.

Change to Text:

[Discussion, Page 21, Line 394-405]

The current study showed that even during the COVID-19 pandemic, total number of elective surgeries for degenerative lumbar spinal disease was maintained, d

Attachment

Submitted filename: Response to reviewers.docx

pone.0305128.s001.docx (35.1KB, docx)

Decision Letter 1

Kentaro Yamada

8 May 2024

PONE-D-23-41698R1Trends in degenerative lumbar spinal surgery during the early COVID-19 pandemic in Republic of Korea: a national study utilizing the National Health Insurance DatabasePLOS ONE

Dear Dr. Kim,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 21 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Kentaro Yamada, M.D., Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Thank you for your lots of efforts to improve article. Please confirm comments from Reviewer #2, then reply for the 2 questions.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

********** 

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

********** 

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

********** 

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the attention and consideration you have shown to my suggested revisions for your manuscript. It is evident that a significant amount of effort and thought has been directed towards the refining of your work, integrating the feedback provided during the peer review process. The resulting modifications demonstrate a thorough approach and significantly improve the rigor and overall quality of your manuscript. I look forward to witnessing the impact your research will undoubtedly have on the academic community.

Reviewer #2: I would like to thank the authors for their considerable effort regarding the revision. My previous comments were appropriately addressed.

Therefore, my decision is provisional accept.

I recommend that the following minor corrections be considered:

1. It seems that something is wrong in the calculation of the number of cases in cohort A in fig 1.

106217-23661-3094-32-702-321=78407

Please confirm this.

2. Still, in my computer environment, the column of CCI in Table 1 seems to be broken; please confirm this.

********** 

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Savvas Lampridis

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jun 11;19(6):e0305128. doi: 10.1371/journal.pone.0305128.r004

Author response to Decision Letter 1


14 May 2024

Response to reviewers

We greatly appreciate the opportunity to revise our manuscript based on the insightful and constructive comments from the reviewers. We are hopeful that the revised manuscript will be considered suitable for publication, thereby making valuable contributions to the field and the journal's readership. We look forward to the potential publication of our work in PLOS ONE and are available to provide any further information or clarifications as needed.

Editor

Additional Editor Comments – Thank you for your lots of efforts to improve article. Please confirm comments from Reviewer #2, then reply for the 2 questions.

Authors’ response:

Thank you for your time and effort in reviewing our manuscript. We are pleased to meet the standards set by the editor and reviewers. The revision process was a true pleasure for all authors, and we hope our study benefits the academic community.

Reviewer #1

Comment - Thank you for the attention and consideration you have shown to my suggested revisions for your manuscript. It is evident that a significant amount of effort and thought has been directed towards the refining of your work, integrating the feedback provided during the peer review process. The resulting modifications demonstrate a thorough approach and significantly improve the rigor and overall quality of your manuscript. I look forward to witnessing the impact your research will undoubtedly have on the academic community.

Authors’ response:

We sincerely appreciate your time and effort in reviewing our manuscript. Based on your comments and suggestions, we have significantly enhanced the quality of our manuscript and incorporated essential points. Thank you for your valuable feedbacks.

Reviewer #2

Comment - I would like to thank the authors for their considerable effort regarding the revision. My previous comments were appropriately addressed. Therefore, my decision is provisional accept.

Authors’ response:

We truly appreciate your time and effort in reviewing our manuscript and are pleased to meet the journal's standards. The revision process was a great experience for all authors. Thank you.

Comment #1 – It seems that something is wrong in the calculation of the number of cases in cohort A in fig 1. 106217-23661-3094-32-702-321=78407 Please confirm this.

Authors’ response:

Thank you for pointing this out. We have confirmed that the first number in the flow chart for the pre-COVID-19 cohort was incorrectly entered as the total number of claims instead of the total number of patients. This has been corrected, and the remaining values have been verified for accuracy. We apologize for any confusion caused.

Comment #2 – Still, in my computer environment, the column of CCI in Table 1 seems to be broken; please confirm this.

Authors’ response – We have re-checked Table 1 on all authors' PCs but could not identify the issue with the broken view. We suggest the editorial office check if there is any problem with Table 1 before publication. We have attached a PDF version of Table 1 for the reviewer to verify the contents. We apologize for any inconvenience. Thank you.

Attachment

Submitted filename: Response to reviewers.docx

pone.0305128.s002.docx (524.4KB, docx)

Decision Letter 2

Kentaro Yamada

24 May 2024

Trends in degenerative lumbar spinal surgery during the early COVID-19 pandemic in Republic of Korea: a national study utilizing the National Health Insurance Database

PONE-D-23-41698R2

Dear Dr. Kim,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Kentaro Yamada, M.D., Ph.D.

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer #1: Thank you for your continued efforts in addressing Reviewer #2’s concern regarding the calculation of the number of cases in cohort A, as depicted in Figure 1. Regarding Reviewer #2’s second comment, I did not find any issues with Table 1 formatting either.

Congratulations on your successful revisions and the forthcoming publication of your work in PLoS One.

Reviewer #2: Thanks for the prompt reply. I have ensured that the authors have appropriately addressed the revisions.

**********

Acceptance letter

Kentaro Yamada

31 May 2024

PONE-D-23-41698R2

PLOS ONE

Dear Dr. Kim,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Kentaro Yamada

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0305128.s001.docx (35.1KB, docx)
    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0305128.s002.docx (524.4KB, docx)

    Data Availability Statement

    In the Republic of Korea (ROK), nearly all residents are beneficiaries of the national health insurance system (NHIS), and all nationwide inpatient and outpatient data regarding diseases and services (i.e., procedures and operations) are coded and registered in the National Health Information Database (NHID) and the Health Insurance Review & Assessment Service (HIRA) database, thus enabling population-based studies to be conducted. The NHID contains demographic characteristics and insurance eligibility information, as well as data on almost all hospitalizations and outpatient medical services. This information encompasses diagnoses, which are based on International Classification of Diseases 10th Revision codes, procedures, prescriptions, examinations, and direct medical costs. We assert that there were no special privileges accorded to the authors in accessing the NHID data. The process followed adheres strictly to the standard protocol provided by NHIS, ensuring equal opportunity for data access to all researchers. The NHIS-NHID data is available to any researchers who are interested by following the appropriate request and review process outlined on the NHIS website (https://nhiss.nhis.or.kr/bd/ab/bdaba032eng.do). There is a cost for the assess to the NHID and the use of virtual terminal.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES